Michael Hurlston

Michael Hurlston
Name	Michael Hurlston
Birth date	1967
Birth place	Belfast, Northern Ireland
Occupation	Business executive, entrepreneur, scientist
Known for	Biopharmaceutical leadership, oncology therapeutics, diagnostics
Alma mater	Queen's University Belfast, Imperial College London

Michael Hurlston

Michael Hurlston is a Northern Irish-born biopharmaceutical executive, entrepreneur, and scientist known for leadership in oncology therapeutics, diagnostics, and corporate development. He has held senior roles at multiple biotechnology and medical device companies, led corporate transactions involving venture capital and public markets, and contributed to translational research bridging academic institutions and industry. His career spans corporate governance, intellectual property strategy, and strategic alliances across the United Kingdom, United States, and Ireland.

Early life and education

Hurlston was born in Belfast and raised during the period of social and political change in Northern Ireland, with formative years influenced by the cultural environments of Belfast, Northern Ireland, and the broader United Kingdom. He attended Queen's University Belfast where he studied biochemical and clinical sciences, later pursuing postgraduate work at Imperial College London with links to translational research initiatives associated with Royal Brompton Hospital and Hammersmith Hospital. His education connected him to research networks including Wellcome Trust, Medical Research Council, and collaborations with academic groups at Trinity College Dublin and University College London.

Business career

Hurlston's business career includes executive and board roles in public and private companies across the Nasdaq and London Stock Exchange. He held senior positions at companies focused on diagnostics, biotechnology, and medical devices, working with venture investors such as SV Health Investors, Sofinnova Partners, and OrbiMed Advisors. He played operational and strategic roles in mergers, acquisitions, and licensing deals involving multinational corporations including Johnson & Johnson, Pfizer, GlaxoSmithKline, and Medtronic. His leadership encompassed working with corporate governance frameworks defined by Financial Conduct Authority listings and Securities and Exchange Commission reporting.

Hurlston was instrumental in scaling companies through series financing rounds and initial public offerings, aligning management teams with investor relations practices common to Goldman Sachs, Morgan Stanley, and J.P. Morgan. He worked closely with legal advisers experienced in biotechnology transactions such as Linklaters, Clifford Chance, and DLA Piper to manage intellectual property and regulatory pathways with agencies like the European Medicines Agency and the Food and Drug Administration.

Scientific and technological contributions

Scientifically, Hurlston contributed to the development and commercialization of diagnostic platforms and targeted therapeutics in oncology, hematology, and rare diseases. His work intersected with technologies and research initiatives tied to next-generation sequencing, companion diagnostics, and biomarker-driven drug development paradigms used by companies such as Roche, Illumina, and Thermo Fisher Scientific. He oversaw translational programs that liaised with academic centers including Dana–Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, and The Institute of Cancer Research.

Hurlston's teams developed partnerships with contract research organizations and manufacturing networks including Catalent, Lonza, and WuXi Biologics to progress biologics and small molecules from discovery through clinical trials governed by International Council for Harmonisation standards. His scientific leadership emphasized combinatorial approaches integrating molecular diagnostics with therapeutics, reflecting strategies used in precision oncology programs at MD Anderson Cancer Center and Johns Hopkins Medicine.

Philanthropy and civic activities

Hurlston has supported philanthropic efforts connecting biomedical research, healthcare access, and regional economic development. His charitable activities involved foundations and institutions such as Cancer Research UK, British Heart Foundation, and university-affiliated endowments at Queen's University Belfast and Trinity College Dublin. He engaged with economic development agencies and innovation hubs, collaborating with bodies like Invest Northern Ireland, Enterprise Ireland, and regional accelerators modeled on Cambridge Biomedical Campus initiatives.

He has participated in advisory capacities for science policy and industry liaison groups, including panels affiliated with the Wellcome Trust, regional innovation networks, and international conferences hosted by BIO International Convention and European Society for Medical Oncology.

Personal life

Hurlston resides between the United Kingdom and United States due to professional commitments and maintains connections to Northern Irish civic and cultural institutions such as Belfast City Hall community programs. Outside his corporate and scientific roles, he has interests aligned with higher education philanthropy and supports student scholarships and translational research fellowships at institutions including Queen's University Belfast and Imperial College London.

Awards and recognition

Hurlston's work has been recognized by industry and academic peers through honorary appointments, industry awards, and speaking invitations at major sector events. He has been invited to present at symposia organized by European Society for Medical Oncology, American Association for Cancer Research, and industry conferences like the JP Morgan Healthcare Conference. He has been listed in sector profiles published by trade organizations and received commendations from university alumni networks at Queen's University Belfast and Imperial College London.

Category:Living people Category:1967 births Category:People from Belfast Category:Biotech executives